# Reward-based Technology to Improve OUD Treatment

> **NCT05180669** · NA · TERMINATED · sponsor: **Q2i, LLC** · enrollment: 41 (actual)

## Conditions studied

- Opioid Use Disorder

## Interventions

- **OTHER:** OARSCM Software Application
- **OTHER:** MyMAT Software Application

## Key facts

- **NCT ID:** NCT05180669
- **Lead sponsor:** Q2i, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-11-18
- **Primary completion:** 2025-05-31
- **Final completion:** 2025-05-31
- **Target enrollment:** 41 (ACTUAL)
- **Why stopped:** Enrollment was impacted by a massive epidemiological shift that led to reduced rates of presentation to the ED for opioid overdose. Despite more than a year of adjusting protocols and site expansion, we were not able to meet study enrollment goals.
- **Last updated:** 2026-02-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05180669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05180669, "Reward-based Technology to Improve OUD Treatment". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT05180669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*